Brief: Omega Therapeutics Reports Second Quarter 2022 Financial Results
04/08/2022 12:46
Aug 4 (Reuters) - Omega Therapeutics Inc OMGA.O :
* OMEGA THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT COMPANY PROGRESS
* $173.7 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES AT END OF Q2
* NET LOSS FOR Q2 OF 2022 WAS $25.9 MILLION
* QTRLY NET LOSS PER COMMON STOCK ATTRIBUTABLE TO
COMMONSTOCKHOLDERS, BASIC AND DILUTED $0.54
* Q2 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn1PpvQla
Further company coverage: OMGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence